SOTAC PHARMACEUTICALS
Back to Income Statement
|
SOTAC PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹4.28 Cr | ₹2.88 Cr | ₹2.88 Cr | ₹-2.37 Cr | ₹0.09 Cr |
What is the latest Consolidated Net Profit of SOTAC PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹4.28 Cr |
| Mar2024 | ₹2.88 Cr |
| Mar2023 | ₹2.88 Cr |
| Mar2022 | ₹-2.37 Cr |
| Mar2021 | ₹0.09 Cr |
How is Consolidated Net Profit of SOTAC PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.28 Cr | 48.65 | |
| Mar2024 | ₹2.88 Cr | 0.03 | |
| Mar2023 | ₹2.88 Cr | Positive | |
| Mar2022 | ₹-2.37 Cr | Negative | |
| Mar2021 | ₹0.09 Cr | - | |
Compare Consolidated Net Profit of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹116.6 Cr | -5.4% | -2.8% | -8.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,093.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,792.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -5.4% |
-2.8% |
-8.3% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses